Hepatitis (HBV)
Enrollment For Phase III Drug Trial In Japan Completed
Published in Hepatitis Weekly, September 17th, 2001
The study involves over 300 patients with chronic hepatitis B virus (HBV) infection. SciClone believes the study is currently one of the largest randomized, double-blind clinical trial using Zadaxin to date. This trial is designed with a six-month treatment period followed by a 12-month long evaluation to specifically address the issue of patient relapse which has been seen in other chronic hepatitis B treatments after therapy is stopped.
Measuring the endpoints of HBV DNA...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2001-09-17)
More Articles from Hepatitis Weekly
- Alternative and Complementary Medicine
Multinational Cohort Urges More Study Of Herbs Before Use For HBV - Medical Practice
U.S. Doctors May Be Falling Short When Managing HCV Patient Care - Alcoholism
Histology And Lab Tests Differentiate Livers In Alcoholics With HCV - Enteric Disease
Gastric Symptoms In Hepatitis A Transient, Involve Gallbladder - Interferon
Zinc Supplementation Enhances HCV Response To Therapy - Therapy
Mutated HBV May Be Present Before Therapy In Some Regions - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
